Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Saxagliptin Market Growth 2022-2028

  • LP 4930387
  • 79 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Saxagliptin will have significant change from previous year. According to our (LP Information) latest study, the global Saxagliptin market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Saxagliptin market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Saxagliptin market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Saxagliptin market, reaching US$ million by the year 2028. As for the Europe Saxagliptin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Saxagliptin players cover Bristol-Myers Squibb Company, AstraZeneca, , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Saxagliptin market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

2.5mg

5mg

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Type 2 Diabetes

Application 2

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Bristol-Myers Squibb Company

AstraZeneca

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Saxagliptin Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Saxagliptin by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Saxagliptin by Country/Region, 2017, 2022 & 2028

2.2 Saxagliptin Segment by Type

2.2.1 2.5mg

2.2.2 5mg

2.3 Saxagliptin Sales by Type

2.3.1 Global Saxagliptin Sales Market Share by Type (2017-2022)

2.3.2 Global Saxagliptin Revenue and Market Share by Type (2017-2022)

2.3.3 Global Saxagliptin Sale Price by Type (2017-2022)

2.4 Saxagliptin Segment by Application

2.4.1 Type 2 Diabetes

2.4.2 Application 2

2.5 Saxagliptin Sales by Application

2.5.1 Global Saxagliptin Sale Market Share by Application (2017-2022)

2.5.2 Global Saxagliptin Revenue and Market Share by Application (2017-2022)

2.5.3 Global Saxagliptin Sale Price by Application (2017-2022)

3 Global Saxagliptin by Company

3.1 Global Saxagliptin Breakdown Data by Company

3.1.1 Global Saxagliptin Annual Sales by Company (2020-2022)

3.1.2 Global Saxagliptin Sales Market Share by Company (2020-2022)

3.2 Global Saxagliptin Annual Revenue by Company (2020-2022)

3.2.1 Global Saxagliptin Revenue by Company (2020-2022)

3.2.2 Global Saxagliptin Revenue Market Share by Company (2020-2022)

3.3 Global Saxagliptin Sale Price by Company

3.4 Key Manufacturers Saxagliptin Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Saxagliptin Product Location Distribution

3.4.2 Players Saxagliptin Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Saxagliptin by Geographic Region

4.1 World Historic Saxagliptin Market Size by Geographic Region (2017-2022)

4.1.1 Global Saxagliptin Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Saxagliptin Annual Revenue by Geographic Region

4.2 World Historic Saxagliptin Market Size by Country/Region (2017-2022)

4.2.1 Global Saxagliptin Annual Sales by Country/Region (2017-2022)

4.2.2 Global Saxagliptin Annual Revenue by Country/Region

4.3 Americas Saxagliptin Sales Growth

4.4 APAC Saxagliptin Sales Growth

4.5 Europe Saxagliptin Sales Growth

4.6 Middle East & Africa Saxagliptin Sales Growth

5 Americas

5.1 Americas Saxagliptin Sales by Country

5.1.1 Americas Saxagliptin Sales by Country (2017-2022)

5.1.2 Americas Saxagliptin Revenue by Country (2017-2022)

5.2 Americas Saxagliptin Sales by Type

5.3 Americas Saxagliptin Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Saxagliptin Sales by Region

6.1.1 APAC Saxagliptin Sales by Region (2017-2022)

6.1.2 APAC Saxagliptin Revenue by Region (2017-2022)

6.2 APAC Saxagliptin Sales by Type

6.3 APAC Saxagliptin Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Saxagliptin by Country

7.1.1 Europe Saxagliptin Sales by Country (2017-2022)

7.1.2 Europe Saxagliptin Revenue by Country (2017-2022)

7.2 Europe Saxagliptin Sales by Type

7.3 Europe Saxagliptin Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Saxagliptin by Country

8.1.1 Middle East & Africa Saxagliptin Sales by Country (2017-2022)

8.1.2 Middle East & Africa Saxagliptin Revenue by Country (2017-2022)

8.2 Middle East & Africa Saxagliptin Sales by Type

8.3 Middle East & Africa Saxagliptin Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Saxagliptin

10.3 Manufacturing Process Analysis of Saxagliptin

10.4 Industry Chain Structure of Saxagliptin

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Saxagliptin Distributors

11.3 Saxagliptin Customer

12 World Forecast Review for Saxagliptin by Geographic Region

12.1 Global Saxagliptin Market Size Forecast by Region

12.1.1 Global Saxagliptin Forecast by Region (2023-2028)

12.1.2 Global Saxagliptin Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Saxagliptin Forecast by Type

12.7 Global Saxagliptin Forecast by Application

13 Key Players Analysis

13.1 Bristol-Myers Squibb Company

13.1.1 Bristol-Myers Squibb Company Company Information

13.1.2 Bristol-Myers Squibb Company Saxagliptin Product Offered

13.1.3 Bristol-Myers Squibb Company Saxagliptin Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bristol-Myers Squibb Company Main Business Overview

13.1.5 Bristol-Myers Squibb Company Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Saxagliptin Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Saxagliptin Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 2.5mg

Table 4. Major Players of 5mg

Table 5. Global Saxagliptin Sales by Type (2017-2022) & (K Units)

Table 6. Global Saxagliptin Sales Market Share by Type (2017-2022)

Table 7. Global Saxagliptin Revenue by Type (2017-2022) & ($ million)

Table 8. Global Saxagliptin Revenue Market Share by Type (2017-2022)

Table 9. Global Saxagliptin Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Saxagliptin Sales by Application (2017-2022) & (K Units)

Table 11. Global Saxagliptin Sales Market Share by Application (2017-2022)

Table 12. Global Saxagliptin Revenue by Application (2017-2022)

Table 13. Global Saxagliptin Revenue Market Share by Application (2017-2022)

Table 14. Global Saxagliptin Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Saxagliptin Sales by Company (2020-2022) & (K Units)

Table 16. Global Saxagliptin Sales Market Share by Company (2020-2022)

Table 17. Global Saxagliptin Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Saxagliptin Revenue Market Share by Company (2020-2022)

Table 19. Global Saxagliptin Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Saxagliptin Producing Area Distribution and Sales Area

Table 21. Players Saxagliptin Products Offered

Table 22. Saxagliptin Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Saxagliptin Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Saxagliptin Sales Market Share Geographic Region (2017-2022)

Table 27. Global Saxagliptin Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Saxagliptin Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Saxagliptin Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Saxagliptin Sales Market Share by Country/Region (2017-2022)

Table 31. Global Saxagliptin Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Saxagliptin Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Saxagliptin Sales by Country (2017-2022) & (K Units)

Table 34. Americas Saxagliptin Sales Market Share by Country (2017-2022)

Table 35. Americas Saxagliptin Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Saxagliptin Revenue Market Share by Country (2017-2022)

Table 37. Americas Saxagliptin Sales by Type (2017-2022) & (K Units)

Table 38. Americas Saxagliptin Sales Market Share by Type (2017-2022)

Table 39. Americas Saxagliptin Sales by Application (2017-2022) & (K Units)

Table 40. Americas Saxagliptin Sales Market Share by Application (2017-2022)

Table 41. APAC Saxagliptin Sales by Region (2017-2022) & (K Units)

Table 42. APAC Saxagliptin Sales Market Share by Region (2017-2022)

Table 43. APAC Saxagliptin Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Saxagliptin Revenue Market Share by Region (2017-2022)

Table 45. APAC Saxagliptin Sales by Type (2017-2022) & (K Units)

Table 46. APAC Saxagliptin Sales Market Share by Type (2017-2022)

Table 47. APAC Saxagliptin Sales by Application (2017-2022) & (K Units)

Table 48. APAC Saxagliptin Sales Market Share by Application (2017-2022)

Table 49. Europe Saxagliptin Sales by Country (2017-2022) & (K Units)

Table 50. Europe Saxagliptin Sales Market Share by Country (2017-2022)

Table 51. Europe Saxagliptin Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Saxagliptin Revenue Market Share by Country (2017-2022)

Table 53. Europe Saxagliptin Sales by Type (2017-2022) & (K Units)

Table 54. Europe Saxagliptin Sales Market Share by Type (2017-2022)

Table 55. Europe Saxagliptin Sales by Application (2017-2022) & (K Units)

Table 56. Europe Saxagliptin Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Saxagliptin Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Saxagliptin Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Saxagliptin Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Saxagliptin Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Saxagliptin Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Saxagliptin Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Saxagliptin Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Saxagliptin Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Saxagliptin

Table 66. Key Market Challenges & Risks of Saxagliptin

Table 67. Key Industry Trends of Saxagliptin

Table 68. Saxagliptin Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Saxagliptin Distributors List

Table 71. Saxagliptin Customer List

Table 72. Global Saxagliptin Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Saxagliptin Sales Market Forecast by Region

Table 74. Global Saxagliptin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Saxagliptin Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Saxagliptin Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Saxagliptin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Saxagliptin Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Saxagliptin Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Saxagliptin Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Saxagliptin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Saxagliptin Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Saxagliptin Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Saxagliptin Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Saxagliptin Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Saxagliptin Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Saxagliptin Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Saxagliptin Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Saxagliptin Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Saxagliptin Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Saxagliptin Revenue Market Share Forecast by Application (2023-2028)

Table 92. Bristol-Myers Squibb Company Basic Information, Saxagliptin Manufacturing Base, Sales Area and Its Competitors

Table 93. Bristol-Myers Squibb Company Saxagliptin Product Offered

Table 94. Bristol-Myers Squibb Company Saxagliptin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Bristol-Myers Squibb Company Main Business

Table 96. Bristol-Myers Squibb Company Latest Developments

Table 97. AstraZeneca Basic Information, Saxagliptin Manufacturing Base, Sales Area and Its Competitors

Table 98. AstraZeneca Saxagliptin Product Offered

Table 99. AstraZeneca Saxagliptin Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. AstraZeneca Main Business

Table 101. AstraZeneca Latest Developments

List of Figures

Figure 1. Picture of Saxagliptin

Figure 2. Saxagliptin Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Saxagliptin Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Saxagliptin Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Saxagliptin Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 2.5mg

Figure 10. Product Picture of 5mg

Figure 11. Global Saxagliptin Sales Market Share by Type in 2021

Figure 12. Global Saxagliptin Revenue Market Share by Type (2017-2022)

Figure 13. Saxagliptin Consumed in Type 2 Diabetes

Figure 14. Global Saxagliptin Market: Type 2 Diabetes (2017-2022) & (K Units)

Figure 15. Saxagliptin Consumed in Application 2

Figure 16. Global Saxagliptin Market: Application 2 (2017-2022) & (K Units)

Figure 17. Global Saxagliptin Sales Market Share by Application (2017-2022)

Figure 18. Global Saxagliptin Revenue Market Share by Application in 2021

Figure 19. Saxagliptin Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Saxagliptin Revenue Market Share by Company in 2021

Figure 21. Global Saxagliptin Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Saxagliptin Revenue Market Share by Geographic Region in 2021

Figure 23. Global Saxagliptin Sales Market Share by Region (2017-2022)

Figure 24. Global Saxagliptin Revenue Market Share by Country/Region in 2021

Figure 25. Americas Saxagliptin Sales 2017-2022 (K Units)

Figure 26. Americas Saxagliptin Revenue 2017-2022 ($ Millions)

Figure 27. APAC Saxagliptin Sales 2017-2022 (K Units)

Figure 28. APAC Saxagliptin Revenue 2017-2022 ($ Millions)

Figure 29. Europe Saxagliptin Sales 2017-2022 (K Units)

Figure 30. Europe Saxagliptin Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Saxagliptin Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Saxagliptin Revenue 2017-2022 ($ Millions)

Figure 33. Americas Saxagliptin Sales Market Share by Country in 2021

Figure 34. Americas Saxagliptin Revenue Market Share by Country in 2021

Figure 35. United States Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Saxagliptin Sales Market Share by Region in 2021

Figure 40. APAC Saxagliptin Revenue Market Share by Regions in 2021

Figure 41. China Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Saxagliptin Sales Market Share by Country in 2021

Figure 48. Europe Saxagliptin Revenue Market Share by Country in 2021

Figure 49. Germany Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Saxagliptin Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Saxagliptin Revenue Market Share by Country in 2021

Figure 56. Egypt Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Saxagliptin Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Saxagliptin in 2021

Figure 62. Manufacturing Process Analysis of Saxagliptin

Figure 63. Industry Chain Structure of Saxagliptin

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390